CD97 is a critical regulator of acute myeloid leukemia stem cell function Journal Article
| Authors: | Martin, G. H.; Roy, N.; Chakraborty, S.; Desrichard, A.; Chung, S. S.; Woolthuis, C. M.; Hu, W.; Berezniuk, I.; Garrett-Bakelman, F. E.; Hamann, J.; Devlin, S. M.; Chan, T. A.; Park, C. Y. |
| Article Title: | CD97 is a critical regulator of acute myeloid leukemia stem cell function |
| Abstract: | Despite significant efforts to improve therapies for acute myeloid leukemia (AML), clinical outcomes remain poor. Understanding the mechanisms that regulate the development and maintenance of leukemic stem cells (LSCs) is important to reveal new therapeutic opportunities. We have identified CD97, a member of the adhesion class of G protein-coupled receptors (GPCRs), as a frequently up-regulated antigen on AML blasts that is a critical regulator of blast function. High levels of CD97 correlate with poor prognosis, and silencing of CD97 reduces disease aggressiveness in vivo. These phenotypes are due to CD97's ability to promote proliferation, survival, and the maintenance of the undifferentiated state in leukemic blasts. Collectively, our data credential CD97 as a promising therapeutic target on LSCs in AML. © 2019 Martin et al. |
| Journal Title: | Journal of Experimental Medicine |
| Volume: | 216 |
| Issue: | 10 |
| ISSN: | 0022-1007 |
| Publisher: | Rockefeller University Press |
| Date Published: | 2019-10-01 |
| Start Page: | 2362 |
| End Page: | 2377 |
| Language: | English |
| DOI: | 10.1084/jem.20190598 |
| PUBMED: | 31371381 |
| PROVIDER: | scopus |
| PMCID: | PMC6781010 |
| DOI/URL: | |
| Notes: | Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work